-
SciClone
- Annual report
Annual report
SciClone Pharmaceuticals is a biopharmaceutical company engaged in the development and commercialisation of novel therapeutics to treat life-threatening diseases.
Annual report
The report was to act as a marketing awareness tool to help investors understand the potential of SciClone's drug Zadaxin.
We featured a number of patient's success stories and their fights with life-threatening diseases. The report articulates the benefits of Zadaxin and the need for alternative medicines.